Division of Cardiovascular Diseases
The National Heart, Lung, and Blood Institute
(NHLBI), one of 27 institutes and centers
at the National Institutes of Health (NIH),
leads a national program in the causes,
diagnosis, treatment, and prevention of
diseases of the heart, blood vessels,
lungs, and blood; in sleep disorders;
and in the uses of blood and blood resources.
The Institute is responsible for research
on three of the four leading causes of
death in the United States—heart
disease, stroke, and chronic obstructive
pulmonary disease. Through research in
its laboratories and through extramural
funding of investigator- and institute-initiated
research grants and contracts, it conducts
and supports scientific research that
includes basic investigations, clinical
studies, epidemiological studies, clinical
trials, technology development and transfer,
and demonstration and education projects.
The Institute also supports research training
and career development awards.
PURPOSE OF THE DIVISION
The Division of Cardiovascular Diseases (DCVD) provides leadership for a national and international extramural program in cardiovascular diseases (CVD) that integrates basic science and clinical research, including translational research, networks, and multicenter clinical trials. It designs, conducts, supports, and oversees research on the causes and prevention and treatment of diseases and disorders such as atherothrombosis; coronary artery disease (CAD); myocardial infarction and ischemia; heart failure; arrhythmia; sudden cardiac death; adult and pediatric congenital heart disease; cardiovascular complications of diabetes and obesity; and hypertension. It also supports and oversees research in vascular medicine and biologyand valvular, cerebral, renal, peripheral, and other cardiovascular disorders . The DCVD fosters biotechnological research in genomics, proteomics, nanotechnology, imaging, device development, cell- and tissue-based therapeutics, and gene therapy, and in their uses as they relate to CVD. It also supports training and career development programs in cardiovascular research at all educational levels from high school students to academic faculty, including programs for individuals from diverse populations.
DCVD STRATEGIC PLAN
The DCVD Strategic Plan was developed to implement strategies outlined in the NHLBI Strategic Plan. DCVD staff defined a series of goals, related to specific clinical problems, disease states, enabling technologies, research methodologies, and training needs. The plan includes 35 goals for research and training accomplishments, that will be used to guide the Division over the next 5 years. These goals were derived principally from the Level One Final Report recommendations germane to the DCVD mission as well as from other workshops and working groups participated in by the scientific and clinical community. The DCVD Strategic Plan is a "living document" and as such will be regularly reviewed and revised to reflect changing needs and directions.
CONTACT INFORMATION
Division of Cardiovascular Diseases
National Heart, Lung, and Blood Institute
Two Rockledge Center - Suite 9160
6701 Rockledge Dr. - MSC 7940
Bethesda, MD 20892-7940
Additional phone numbers are available
in the Abbreviated
Staff Directory.
September 2008 |